Loading
Life sciences · Journal article
International Journal of Advanced Research in Science Communication and Technology · October 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Breast cancer remains a leading global health burden, characterized by profound biological and clinical heterogeneity. This review synthesizes modern advancements in epidemiology, genetic vulnerability, and histopathological classification, while examining the paradigm shift from broad systemic treatments to high-resolution precision oncology. We outline key diagnostic innovations, including digital breast tomosynthesis, artificial intelligence integration, and liquid biopsies. Furthermore, we dissect standard treatment algorithms, focusing on local therapy de-escalation, CDK4/6 inhibitor pathways, and the transformative clinical impact of antibody-drug conjugates (ADCs) and immunotherapy. By consolidating these updates into a streamlined framework, this review provides a definitive clinical overview for clinicians and researchers. (1).